Skip to main content
Download PDF

Novel PIP5K1C variant identified in a Chinese pedigree with lethal congenital contractural syndrome 3

BMC Pediatrics volume 24, Article number: 182 (2024) Cite this article

Abstract

Background

Biallelic pathogenic variants in PIP5K1C (MIM #606,102) lead to lethal congenital contractural syndrome 3 (LCCS3, MIM #611,369), a rare autosomal recessive genetic disorder characterized by small gestational age, severe multiple joint contractures and muscle atrophy, early death due to respiratory failure. Currently, 5 individuals with LCCS3 were reported and 5 pathogenic variants in PIP5K1C were identified. Here, we reported the two fetuses in a Chinese pedigree who displayed multiple joint contractures and other congenital anomalies.

Methods

Trio-based whole-exome sequencing (WES) was performed for the parents and the recent fetus to detect the genetic cause for fetus phenotype.

Results

A novel variant, NM_012398.3: c.949_952dup, p.S318Ifs*28 and a previously reported variant, c.688_689del, p.G230Qfs*114 (ClinVar database) in PIP5K1C, were detected in the individuals, and these variants were inherited from the mother and father, respectively. We described the features of multiple joint contractures in our fetuses, including bilateral talipes equinovarus, stiffness in the limbs, extended knees, persistently closed hands and overlapping fingers, which have not been delineated detailedly in previously reported LCCS3 individuals. Furthermore, novel phenotype, bilateral dilated lateral ventricles, was revealed in one fetus.

Conclusions

These findings expanded the genetic variant spectrum of PIP5K1C and enriched the clinical features of LCCS3, which will help with the prenatal diagnosis and genetic counseling for this family.

Peer Review reports

Background

Lethal congenital contracture syndrome (LCCS) is a heterogenous group of congenital genetic condition. It is characterized by multiple joint contractures, polyhydramnios and reduced fetal movement, often leading to the perinatal or neonatal death. Studies have suggested that LCCS is an autosomal recessive disorder causally linked to 11 genes, including GLE1, ERBB3, PIP5K1C, MYBPC1, DNM2, ZBTB42, CNTNAP1, ADCY6, ADGRG6, NEK9 and GLDN. Among them, LCCS1 (MIM #253,310), LCCS7 (MIM #607,598) and LCCS11 (MIM #617,194) have been relatively frequent reported in the literature [1,2,3,4,5,6]. However, lethal congenital contracture syndrome 3 (LCCS3 MIM #611,369), caused by biallelic pathogenic variants in PIP5K1C (MIM #606,102), was rarely reported.

The PIP5K1C gene consists of 18 exons and encodes a 668-amino acid enzyme. This protein utilizes phosphatidylinositol 4-phosphate (PI4P) as a substrate to synthesize phosphatidylinositol 4,5-phosphate (PIP2) on the cell membrane [7, 8]. PIP5K1C belongs to the PIP5K1 family of enzymes, which are classified as type I phosphatidylinositol-4-phosphate 5-kinases. This family consists of three subtypes: PIP5K1A, PIP5K1B, and PIP5K1C. PIP5K1A is predominantly expressed in skeletal muscle, while PIP5K1B has the highest expression in the heart. To date, only 5 individuals with LCCS3 have been reported; 5 pathogenic variants in PIP5K1C have been identified [9, 10, ClinVar]. Here, we reported two additional individuals in a Chinese pedigree with LCCS3 caused by pathogenic variants in PIP5K1C. The individuals displayed some phenotypes rarely reported before. And one novel variant in PIP5K1C, c.949_952dup, p.S318Ifs*28 (NM_012398.3), was identified. The results of our study expanded the genetic variant spectrum of PIP5K1C and enriched our understanding of the clinical characteristics of this disorder, which will be beneficial for improving the prenatal diagnosis and genetic counseling for individuals with LCCS3.

Materials and methods

Ethical compliance

The Ethics Committee of Dongguan Maternal and Child Health Hospital (DMCH 202,307) approved this study, and written informed consent was obtained from the legal guardian for the release of any potentially identifiable image or data contained in this paper.

Trio-based whole-exome sequencing

Trio-based whole-exome sequencing (WES) was performed for the pedigree to screen for causal variants. Sequencing was performed with an Illumina NovaSeq 6000 (Illumina, San Diego, CA, USA). Suspected variants were verified by Sanger sequencing. The pathogenicity of the variants was interpreted according to the ACMG/AMP guidelines [11].

Results

Clinical report

The two affected individuals were from a Chinese nonconsanguineous couple (Fig. 1A). The 41-year-old woman has given birth to two healthy children and experienced two eventful pregnancies. One of eventful pregnancies occurred six years ago, a prenatal ultrasound scan showed limited fetal movement, bilateral talipes equinovarus, flexion contractures of fingers and overlapping fingers at 23 weeks (Fig. 1B, II-2). Then, she underwent vaginal delivery prematurely at 26 weeks, and the baby passed away after birth due to respiratory failure. In the recent pregnancy, the woman sought medical attention due to advanced maternal age and progressively reduced fetal movement. At 23 weeks of gestation, a prenatal ultrasound scan revealed bilateral dilated lateral ventricles (13.4 mm). Additionally, the fetus exhibited stiffness in the limbs, extended knees, bilateral talipes equinovarus and persistently closed hands (Fig. 1B, II-4). The karyotype analysis and chromosomal microarray of the amniotic fluid were normal. MLPA detected no deletion of exons 7 and 8 in SMN1.

Fig. 1
figure 1

The pedigree chart and radiographic findings for the two fetuses. (A). Pedigree for a consanguineous Chinese family with LCCS3 (The black arrow represents the proband, translucent grey indicates carrier). (B). Radiographic findings for the two fetuses. (II-2) bilateral talipes equinovarus (a), flexion contractures of fingers and overlapping fingers (b). (II-4) bilateral dilated lateral ventricles (13.4 mm) (c), stiffness in the limbs, extended knees (d), bilateral talipes equinovarus (e) and persistently closed hands (f)

Full size image

Genetic analysis

Compound heterozygous variants, NM_012398.3: c.949_952dup (p.S318Ifs*28) and c.688_689del (p.G230Qfs*114) in PIP5K1C, were revealed in II-4, which were inherited from the mother and father. Next, we analyzed the DNA sample of II-2, and it expectedly revealed the same PIP5K1C compound heterozygous variants. Sanger sequencing verification was performed for other members in the pedigree. Individual II-1 was proven to be wildtype and individual II-3 was an asymptomatic carrier (c.949_952dup, p.S318Ifs*28 in PIP5K1C). The variant segregates as autosomal recessive (Fig. 2). The paternally inherited frameshift variant, (c.688_689del, p.G230Qfs*114), has been reported in ClinVar database. The maternally inherited novel variant, c.949_952dup (p.S318Ifs*28), was predicted to cause protein truncation and was unlikely escape nonsense-mediated mRNA decay. In addition, the individuals’ phenotypes were highly consistent with that of LCCS3. Trio-based WES also excluded other possible known genetic causes. Thus, both variants were categorized as clinically pathogenic according to the ACMG/AMP guidelines. (PVS1 + PM2 + PP1 + PP4).

Fig. 2
figure 2

Variant confirmation by Sanger sequencing. Compound heterozygous variants NM_012398.3: c.688_689del and c.949_952dup in PIP5K1C were detected in both fetuses and their asymptomatic parents and siblings. The red arrow indicates the variant site

Full size image

Discussion

PIP5K1C is mainly highly expressed in brain and plays an important role in neural signaling pathway [12, 13]. Pip5k1c -/- mice caused a 50% reduction in PIP2 in brain, leading to an impairment of its depolarization-dependent synthesis in nerve terminals and synaptic defects [14]. PIP5K1C has been demonstrated to regulate various cellular processes including receptor-mediated calcium signaling transmission, actin cytoskeleton dynamics, endocytosis and exocytosis [15]. Additionally, PIP5K1C plays a crucial role in the maintenance of bone development. It exerts its influence on bone growth and development by regulating the movement of calcium ions in cells and body fluids [8].

Homozygous or compound heterozygous variants in PIP5K1C have been known to cause LCCS3 through haploinsufficiency mechanisms. LCCS3 was a very rare and severe disorder. To date, 5 variants were identified in PIP5K1C. In this study, we revealed a novel variant (c.949_952dup, p.S318Ifs*28) in PIP5K1C (Fig. 3). The expanded mutation spectrum in PIP5K1C improves the molecular diagnosis of LCCS3. It was observed that all pathogenic variants in PIP5K1C were located in the PIPK domain (76-449aa). The variants (c.688_689del, p.G230Qfs*114 and c.727G > A, p.D253N) seem to be mutation hotspots. Certainly, it was necessary to add more clinical cases to further expand mutation spectrum.

Fig. 3
figure 3

Schematic representation of PIP5K1C variants identified to date. The structure of PIP5K1C contained 18 exons (green rectangles) and introns (grey horizontal line). Lower side: the PIP5K1C protein domains: PIPK domain (76-449aa). The localization of variants and substitutions identified is depicted with dots. Black: Variants reported in the literature or ClinVar database; Red: Novel variants identified in this study

Full size image

Currently, only 7 LCCS3 individuals with detailed clinical information, including the two individuals here, have been described (Table 1). All individuals presented with dyskinesia and multiple joint contractures. Novel phenotypes, bilateral dilated lateral ventricles, were observed in our fetus 2 (II-4), which may be related to the high expression of PIP5K1C in the brain. However, our fetus 1 (II-2) did not show this feature. It indicates that the PIP5K1C variant can cause phenotypic variability even within the same family. Furthermore, it has been reported that individuals with LCCS7 or LCCS9 also displayed various brain anomalies, such as cerebral and cerebellar atrophy with almost no white matter, thin corpus callosum, and small basal ganglia and hippocampi [16, 17]. Whether brain anomaly observed in our fetus 2 is truly part of the spectrum of LCCS3 or is a coincidental finding remains to be further investigated. Although multiple joint contractures have been reported as a feature of LCCS3, the detailed phenotypes have not been displayed [9]. Here, we presented detailed presentations of multiple joint contractures in our two fetuses, including bilateral talipes equinovarus, stiffness in the limbs, extended knees, flexion contractures of fingers and overlapping fingers. Talipes equinovarus has previously been observed in individuals with LCCS9 and 10 [18, 19], here our two fetuses also exhibited bilateral talipes equinovarus. Ankylosis of knee joint was observed in individuals with LCCS6, 7 and 9, here our fetus 2 (II-4) showed this feature [5, 18, 20]. Flexion contractures of fingers were reported in individuals with LCCS7, 9, 10, 11, which was also observed in our two fetuses [5, 18,19,20,21]. Our findings profiled the picture of multiple joint contractures in LCCS3. Polyhydramnios was a marked feature of LCCS [16,17,18,19,20,21,22,23,24,25]. However, this feature has not yet been observed in individuals with LCCS3, which deserves further investigation.

Table 1 Overview of variants and phenotypes observed in patients with LCCS3
Full size table

In conclusion, we described in detail the prenatal clinical features of a Chinese pedigree with LCCS3 caused by biallelic pathogenic variants in PIP5K1C. The identification of the novel variant and novel phenotypes expands the variant spectrum of PIP5K1C and enriches the clinical characteristics of LCCS3, which will be valuable for prenatal diagnosis and genetic counseling.

Data availability

The datasets for this article are not publicly available due to concerns regarding participant/patient anonymity. Requests to access the datasets should be directed to the corresponding author.

References

  1. Stals KL, Wakeling M, Baptista J, Caswell R, Parrish A, Rankin J, et al. Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing. Prenat Diagn. 2018;38(1):33–43. https://doi.org/10.1002/pd.5175.

    Article  CAS  PubMed  Google Scholar 

  2. Laquerriere A, Jaber D, Abiusi E, Maluenda J, Mejlachowicz D, Vivanti A, et al. Phenotypic spectrum and genomics of undiagnosed arthrogryposis multiplex congenita. J Med Genet. 2022;59(6):559–67. https://doi.org/10.1136/jmedgenet-2020-107595.

    Article  CAS  PubMed  Google Scholar 

  3. Yates TM, Campeau PM, Ghoumid J, Kibaek M, Larsen MJ, Smol T, et al. Biallelic variants in GLE1 with survival beyond neonatal period. Clin Genet. 2020;98(6):622–5. https://doi.org/10.1111/cge.13841.

    Article  CAS  PubMed  Google Scholar 

  4. Vanderver A, Simons C, Helman G, Crawford J, Wolf NI, Bernard G, et al. Whole exome sequencing in patients with white matter abnormalities. Ann Neurol. 2016;79(6):1031–7. https://doi.org/10.1002/ana.24650.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Laquérriere A, Maluenda J, Camus A, Fontenas L, Dieterich K, Nolent F, et al. Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects. Hum Mol Genet. 2014;23(9):2279–89. https://doi.org/10.1093/hmg/ddt618.

    Article  CAS  PubMed  Google Scholar 

  6. Pergande M, Motameny S, Özdemir Ö, Kreutzer M, Wang H, Daimagüler HS, et al. The genomic and clinical landscape of fetal akinesia. Genet Med. 2020;22(3):511–23. https://doi.org/10.1038/s41436-019-0680-1.

    Article  CAS  PubMed  Google Scholar 

  7. Xu W, Jin M, Huang W, Wang H, Hu R, Li J, Cao Y, Apical. PtdIns(4,5)P(2) is required for ciliogenesis and suppression of polycystic kidney disease. FASEB J. 2019;33(2):2848–57. https://doi.org/10.1096/fj.201800385RRR.

    Article  CAS  PubMed  Google Scholar 

  8. Yan Q, Gao H, Yao Q, Ling K, Xiao G. Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling. J Biol Chem. 2022;298(3):101639. https://doi.org/10.1016/j.jbc.2022.101639.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Narkis G, Ofir R, Landau D, Manor E, Volokita M, Hershkowitz R, et al. Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway. Am J Hum Genet. 2007;81(3):530–9. https://doi.org/10.1086/520771.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696–704. https://doi.org/10.1038/gim.2015.148.

    Article  CAS  PubMed  Google Scholar 

  11. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. https://doi.org/10.1038/gim.2015.30.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Legate KR, Montag D, Bottcher RT, Takahashi S, Fassler R. Comparative phenotypic analysis of the two major splice isoforms of phosphatidylinositol phosphate kinase type igamma in vivo. J Cell Sci. 2012;125(23):5636–46. https://doi.org/10.1242/jcs.102145.

    Article  CAS  PubMed  Google Scholar 

  13. White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, Bussell JN, et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell. 2013;154(2):452–64. https://doi.org/10.1016/j.cell.2013.06.022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Di Paolo G, Moskowitz HS, Gipson K, Wenk MR, Voronov S, Obayashi M, et al. Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature. 2004;431(7007):415–22. https://doi.org/10.1038/nature02896.

    Article  ADS  CAS  PubMed  Google Scholar 

  15. Yu YL, Chou RH, Chen LT, Shyu WC, Hsieh SC, Wu CS, et al. EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling. J Biol Chem. 2011;286(11):9657–67. https://doi.org/10.1074/jbc.M110.185124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lakhani S, Doan R, Almureikhi M, Partlow JN, Al Saffar M, Elsaid MF, et al. Identification of a novel CNTNAP1 mutation causing arthrogryposis multiplex congenita with cerebral and cerebellar atrophy. Eur J Med Genet. 2017;60(5):245–9. https://doi.org/10.1016/j.ejmg.2017.02.006.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hosseini M, Fattahi Z, Abedini SS, Hu H, Ropers HH, Kalscheuer VM, et al. GPR126: a novel candidate gene implicated in autosomal recessive intellectual disability. Am J Med Genet A. 2019;179(1):13–9.

    Article  CAS  PubMed  Google Scholar 

  18. Ravenscroft G, Nolent F, Rajagopalan S, Meireles AM, Paavola KJ, Gaillard D, et al. Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita. Am J Hum Genet. 2015;96(6):955–61. https://doi.org/10.1016/j.ajhg.2015.04.014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Casey JP, Brennan K, Scheidel N, McGettigan P, Lavin PT, Murphy H, et al. Recessive NEK9 mutation causes a lethal skeletal dysplasia with evidence of cell cycle and ciliary defects. Hum Mol Genet. 2016;25(9):1824–35. https://doi.org/10.1093/hmg/ddw054.

    Article  CAS  PubMed  Google Scholar 

  20. Patel N, Smith LL, Faqeih E, Mohamed J, Gupta VA, Alkuraya FS. ZBTB42 mutation defines a novel lethal congenital contracture syndrome (LCCS6). Hum Mol Genet. 2014;23(24):6584–93. https://doi.org/10.1093/hmg/ddu384.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Maluenda J, Manso C, Quevarec L, Vivanti A, Marguet F, Gonzales M, et al. Mutations in GLDN, Encoding Gliomedin, a critical component of the nodes of Ranvier, are responsible for Lethal Arthrogryposis. Am J Hum Genet. 2016;99(4):928–33. https://doi.org/10.1016/j.ajhg.2016.07.021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Landau D, Mishori-Dery A, Hershkovitz R, Narkis G, Elbedour K, Carmi R. A new autosomal recessive congenital contractural syndrome in an Israeli Bedouin kindred. Am J Med Genet A. 2003;117A(1):37–40. https://doi.org/10.1002/ajmg.a.10894.

    Article  PubMed  Google Scholar 

  23. Koutsopoulos OS, Kretz C, Weller CM, Roux A, Mojzisova H, Bohm J, et al. Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome. Eur J Hum Genet. 2013;21(6):637–42. https://doi.org/10.1038/ejhg.2012.226.

    Article  CAS  PubMed  Google Scholar 

  24. Markus B, Narkis G, Landau D, Birk RZ, Cohen I, Birk OS. Autosomal recessive lethal congenital contractural syndrome type 4 (LCCS4) caused by a mutation in MYBPC1. Hum Mutat. 2012;33(10):1435–8. https://doi.org/10.1002/humu.22122.

    Article  CAS  PubMed  Google Scholar 

  25. Nousiainen HO, Kestila M, Pakkasjarvi N, Honkala H, Kuure S, Tallila J, et al. Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nat Genet. 2008;40(2):155–7. https://doi.org/10.1038/ng.2007.65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to express our sincere gratitude to the pedigree for their cooperation. Furthermore, we extend our thanks to all the colleagues who actively participated in this study.

Funding

This study was supported by the Dongguan Social Development Project (No. 20221800900532 to Jianhua Luo). The funding body participated in the design of the project and interpretation of whole exome sequencing.

Author information

Author notes

  1. Fang Zhang and Hongmei Guo contributed equally to this work.

Authors and Affiliations

  1. Dongguan Maternal and Child Health Care Hospital, Dongguan, 523120, China

    Fang Zhang, Hongmei Guo, Xinlong Zhou, Zhengxi Deng, Qiuhong Xu, Qingming Wang, Haiming Yuan & Jianhua Luo

  2. Department of Medical Genetics, Dongguan Maternal and Child Health Care Hospital, Dongguan, 523120, China

    Qingming Wang & Haiming Yuan

  3. Key Laboratory for Precision Diagnosis and Treatment of Severe Infectious Diseases in Children, Dongguan, 523120, China

    Xinlong Zhou

Authors
  1. Fang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongmei Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xinlong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhengxi Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiuhong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qingming Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haiming Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jianhua Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FZ drafted the first versions of the manuscript. HMY and JHL were responsible for the design of the project, data analysis, and revised the manuscript. HMG, ZXD, QHX made the clinical evaluation and collected clinical information of the patients in detail. XLZ provided financial support. QMW performed the experiments and data entry.

Corresponding authors

Correspondence to Haiming Yuan or Jianhua Luo.

Ethics declarations

Ethics approval and consent to participate

The studies involving human participants were reviewed and approved by ethics committee of Dongguan Maternal and Child Health Hospital. Written informed consent was obtained from the patient’s parents for publication.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, F., Guo, H., Zhou, X. et al. Novel PIP5K1C variant identified in a Chinese pedigree with lethal congenital contractural syndrome 3. BMC Pediatr 24, 182 (2024). https://doi.org/10.1186/s12887-024-04674-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-04674-6

Keywords

BMC Pediatrics

ISSN: 1471-2431

Contact us